# Content and Format of INDs for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic, Biotechnology-Derived Products  Questions and Answers:  Guidance for Industry Q&A - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/content-and-format-of-inds-for-phase-1-studies-of-drugs-including-well-characterized-therapeutic-biotechnology-derived-products-questions-and-answers-guidance-for-industry-qa/0b58e6c1-3ce5-461a-be2e-38697dc3a308

> FDA guidance document: Content and Format of INDs for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic, Biotechnology-Derived Products  Questions and Answers:  Guidance for Industry Q&A. Issue date: October 01, 2000. Get complete insights and analysis.

---

## Details

- Title: Content and Format of INDs for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic, Biotechnology-Derived Products  Questions and Answers:  Guidance for Industry Q&A
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2000-10-01
- Last Changed: 2020-05-06
- Docket Number: <a href="https://www.regulations.gov/docket/None found">None found</a>

## Related Documents

- [IND Exemptions for Studies of Lawfully Marketed Drug or Biological Products for the Treatment of Cancer:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/ind-exemptions-for-studies-of-lawfully-marketed-drug-or-biological-products-for-the-treatment-of-cancer-guidance-for-industry/fa85146f-e37f-41a7-a38d-60e7f38b337d)
- [E11 Clinical Investigation of Medicinal Products in the Pediatric Population](https://www.globalkeysolutions.net/guidances/guidance-document/e11-clinical-investigation-of-medicinal-products-in-the-pediatric-population/22e34547-3d8e-42d2-a67f-98b794654491)
- [Cancer Drug and Biological Products - Clinical Data in Marketing Applications](https://www.globalkeysolutions.net/guidances/guidance-document/cancer-drug-and-biological-products-clinical-data-in-marketing-applications/46d12435-8972-4d63-a8eb-3c3d753c0178)